FIELD: medicine.
SUBSTANCE: method involves measuring carbonyl protein derivatives concentration in pregnant woman blood serum at early stage (beginning from 5 weeks). The value being equal to 51.7 optic density units/g of protein or higher, gestosis development is predicted.
EFFECT: high prognosis accuracy in preclinical period.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF PREECLAMPSIA IN SECOND TRIMESTER OF PREGNANCY | 2014 |
|
RU2552931C1 |
METHOD FOR EVALUATING THE DEGREE OF GESTOSIS SEVERITY | 2006 |
|
RU2309412C1 |
DIAGNOSTIC TECHNIQUE FOR SEVERE GESTOSIS | 2011 |
|
RU2476880C1 |
METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
METHOD FOR PREDICTION OF ONSET OF GESTOSIS IN PREGNANT WOMEN | 2011 |
|
RU2478960C2 |
METHOD FOR GENETIC MARKER PREDICTION OF RISK OF GESTOSIS | 2010 |
|
RU2431842C1 |
METHOD FOR FORECASTING DEVELOPMENT OF PRE-ECLAMPSIA IN LATE PREGNANCY | 2018 |
|
RU2691114C1 |
METHOD FOR EARLY PREDICTION OF FETAL GROWTH RETARDATION | 2019 |
|
RU2718725C1 |
METHOD FOR PREDICTING GESTOSIS DEVELOPMENT IN EARLY PREGNANCY PERIOD | 1999 |
|
RU2154823C1 |
METHOD FOR PREDICTING LATE GESTOSIS | 1995 |
|
RU2107916C1 |
Authors
Dates
2005-03-27—Published
2003-08-19—Filed